Clinical Trials Browser

Triple Negative Breast Neoplasms × CLR1404 × 90 days × Clear all

NCT07311993 2026-06-03

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Phase 1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms